ELIZABETH BLAKE: Open Payments
NPI 1295152908 · CROWLEY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 41 payments from 16 companies in 2025. Trend: 2023 $448 · 2024 $226 · 2025 $784
Food & beverage: $784
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $93 |
| Lilly USA, LLC | 5 | $92 |
| Amgen Inc. | 4 | $73 |
| ABBVIE INC. | 3 | $62 |
| Ardelyx, Inc. | 4 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| Abbott Laboratories | 2 | $44 |
| Verona Pharma, Inc. | 2 | $39 |
| Exact Sciences Corporation | 2 | $38 |
Products named: Auvelity, CAPLYTA, MOUNJARO, VRAYLAR, IBSRELA, EVENITY, FREESTYLE LIBRE 3, Ohtuvayre.
Industry payments across LA — which companies pay providers there.
